Biden directive on screening foreign investments in US biotech not targeted at China, admin officials say
President Joe Biden yesterday signed a new executive order, largely ceremonial in nature, but targeted and clearly drawing attention to foreign investments in the US in the areas of biotech and other sensitive tech like AI and semiconductors.
At the heart of the directive is the Committee on Foreign Investment in the United States (CFIUS), housed in the Treasury department, which is authorized to review certain sensitive transactions involving foreign investment in the US, including real estate purchases, but has typically stayed within the boundaries of Defense-related companies.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 150,300+ biopharma pros reading Endpoints daily — and it's free.